Related Experiment Video
Updated: Jul 10, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor
Jiang Li1, Xue-hui Zeng, Hao-yuan Mo
1State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
Abstract:
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated malignancy with high prevalence in Southern Chinese. In order to assess whether defects of EBV-specific immunity may contribute to the tumor, the phenotype and function of circulating T-cells and tumor infiltrating lymphocytes (TILs) were investigated in untreated NPC patients. Circulating naïve CD3+CD45RA+ and CD4+CD25- cells were decreased, while activated CD4+CD25+ T-cells and CD3-CD16+ NK-cells were increased in patients compared to healthy donors. The frequency of T-cells recognizing seven HLA-A2 restricted epitopes in LMP1 and LMP2 was lower in the patients and remained low after stimulation with autologous EBV-carrying cells. TILs expanded in low doses of IL-2 exhibited an increase of CD3+CD4+, CD3+CD45RO+ and CD4+CD25+ cells and 2 to 5 fold higher frequency of LMP1 and LMP2 tetramer positive cells compared to peripheral blood. EBV-specific cytotoxicity could be reactivated from the blood of most patients, whereas the TILs lacked cytotoxic activity and failed to produce IFNgamma upon specific stimulation. Thus, EBV-specific rejection responses appear to be functionally inactivated at the tumor site in NPC.
Insights
Nasopharyngeal carcinoma (NPC) is linked to Epstein-Barr virus (EBV). This study found that while EBV-specific T-cells show defects in NPC patients, tumor-infiltrating lymphocytes are inactivated at the tumor site, hindering immune response.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer prevalent in Southern China.
- Understanding the host immune response to EBV in NPC is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the phenotype and function of T-cells and tumor-infiltrating lymphocytes (TILs) in untreated NPC patients.
- To determine if defects in EBV-specific immunity contribute to NPC development and progression.
Main Methods:
- Analysis of circulating T-cell subsets (naïve, activated, regulatory) and NK-cells in NPC patients versus healthy donors.
- Assessment of T-cell responses to EBV-specific epitopes (LMP1, LMP2) using HLA-A2 tetramers.
- Expansion and functional analysis of TILs, including cytotoxicity and cytokine production (IFN-gamma).
Main Results:
- NPC patients showed decreased circulating naïve T-cells and increased activated T-cells and NK-cells.
- Reduced frequency of EBV-specific T-cells recognizing LMP1/LMP2 epitopes in patients.
- TILs exhibited altered T-cell populations but lacked cytotoxic activity and IFN-gamma production upon specific stimulation, despite potential for reactivation from peripheral blood.
Conclusions:
- EBV-specific T-cell responses are impaired in the peripheral blood of NPC patients.
- Tumor-infiltrating lymphocytes in NPC are functionally inactivated at the tumor site, suggesting a mechanism of immune evasion.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis
Mitogens and the Cell Cycle
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...